Citation Impact
1 by Nobel laureates 5 from Science/Nature 60 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Natural killer cell therapies
2024 StandoutNature
Works of Daniel Gliddon being referenced
FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Exhibits Low Toxicity and Antitumor Activity in Colorectal Cancer Models
2020
Abstract 2719: Dual blockade of PD-L1 and LAG-3 with FS118, a unique bispecific antibody, induces CD8+ T-cell activation and modulates the tumor microenvironment to promote antitumor immune responses
2018
Author Peers
| Author | Oncology | Immunology | RNMI | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Daniel Gliddon | 160 | 201 | 67 | 15 | 301 | |
| Luke W. Barker | 126 | 47 | 63 | 10 | 299 | |
| William Roger Louis | 27 | 342 | ||||
| Felip Miralles | 5 | 3 | 36 | 450 | ||
| Tony Chapman | 11 | 5 | 26 | 503 |
All Works
Login with ORCID to disown or claim papers
Loading papers...